Beyond Achondroplasia

Growing together with Clara

March 28, 2016
by inesp.alves
1 Comment

Patent and license agreement for CNP

Article credits: “the pharma letter” Chugai and BioMarin ink exclusive sublicense agreement   Japanese drug major Chugai Pharmaceutical (TYO: 4519) has concluded an exclusive sublicense agreement with US rare disease drug developer BioMarin Pharmaceutical (Nasdaq: BMRN) on the patent of Chugai’s … Continue reading

July 23, 2013
by inesp.alves

Patent: Therapeutic agents for achondroplasia

Searching online about achondroplasia, I found a (the?) patent of the discovery of the use of CNP in achondroplasia. It was released in 2004! by Kasuwa Nakao. It seems to be the basis for the analog BioMarin developed. This pharmaceutical … Continue reading

Translate »